Drug class
Anthraquinone stimulant laxative (historical agent)
Mechanism of action
Stimulates colonic motility and reduces net water and electrolyte absorption in the large intestine, increasing bowel evacuation. The exact mechanism is not fully characterised; use was restricted because of carcinogenicity concerns.
General use cases
- Historical short-term treatment of constipation. Dantron-containing laxatives have been withdrawn or restricted in many jurisdictions due to genotoxicity and carcinogenicity concerns and should not be presented as routine current therapy.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
